Combining epigenetic drugs with other therapies for solid tumours—past lessons and future promise

D Morel, D Jeffery, S Aspeslagh, G Almouzni… - Nature Reviews …, 2020 - nature.com
Epigenetic dysregulation has long been recognized as a key factor contributing to
tumorigenesis and tumour maintenance that can influence all of the recognized hallmarks of …

DNA damage response in cancer therapy and resistance: challenges and opportunities

D Jurkovicova, CM Neophytou, AČ Gašparović… - International Journal of …, 2022 - mdpi.com
Resistance to chemo-and radiotherapy is a common event among cancer patients and a
reason why new cancer therapies and therapeutic strategies need to be in continuous …

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and …

SI Jawed, PL Myskowski, S Horwitz… - Journal of the American …, 2014 - Elsevier
Mycosis fungoides (MF) and Sézary syndrome (SS) comprise approximately 53% of
cutaneous lymphomas. Both MF and SS may clinically and histologically mimic benign skin …

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

KM Miller, JV Tjeertes, J Coates, G Legube… - Nature structural & …, 2010 - nature.com
DNA double-strand break (DSB) repair occurs within chromatin and can be modulated by
chromatin-modifying enzymes. Here we identify the related human histone deacetylases …

Histone deacetylase inhibitors in cancer therapy

AA Lane, BA Chabner - Journal of clinical oncology, 2009 - ascopubs.org
Purpose Epigenetic processes are implicated in cancer causation and progression. The
acetylation status of histones regulates access of transcription factors to DNA and influences …

[HTML][HTML] HDAC inhibitor-based therapies: can we interpret the code?

M New, H Olzscha, NB La Thangue - Molecular oncology, 2012 - Elsevier
Abnormal epigenetic control is a common early event in tumour progression, and aberrant
acetylation in particular has been implicated in tumourigenesis. One of the most promising …

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions

SI Jawed, PL Myskowski, S Horwitz… - Journal of the American …, 2014 - Elsevier
Both mycosis fungoides (MF) and Sézary syndrome (SS) have a chronic, relapsing course,
with patients frequently undergoing multiple, consecutive therapies. Treatment is aimed at …

Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer

G Sulli, R Di Micco, FA di Fagagna - Nature Reviews Cancer, 2012 - nature.com
The generation of DNA lesions and the resulting activation of DNA damage response (DDR)
pathways are both affected by the chromatin status at the site of damaged DNA. In turn, DDR …

HDAC expression and clinical prognosis in human malignancies

W Weichert - Cancer letters, 2009 - Elsevier
Histone deacetylases are known to play a central role in the regulation of several cellular
properties intimately interlinked with the development and progression of cancer …

Screen for DNA‐damage‐responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells

JV Tjeertes, KM Miller, SP Jackson - The EMBO journal, 2009 - embopress.org
Recognition and repair of damaged DNA occurs within the context of chromatin. The key
protein components of chromatin are histones, whose post‐translational modifications …